Kidney cancer, Renal cell cancer
Results
Phase 3
This trial looked at a vaccine called IMA901 alongside sunitinib for renal cell cancer (kidney cancer) that has spread.
Recruitment start: 22 December 2010
Recruitment end: 21 September 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Eisen
Experimental Cancer Medicine Centre (ECMC)
Immatics
NIHR Clinical Research Network: Cancer
Last reviewed: 11 Feb 2020
CRUK internal database number: 8577